Opioid – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Mon, 29 Nov 2021 23:43:07 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Opioid – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain https://www.cannabisclinicians.org/2021/11/29/perceived-efficacy-reduced-prescription-drug-use-and-minimal-side-effects-of-cannabis-in-patients-with-chronic-orthopedic-pain/ Mon, 29 Nov 2021 23:43:07 +0000 https://www.cannabisclinicians.org/?p=25307 The most important discoveries in pharmacology, such as certain classes of analgesics or chemotherapeutics, started from natural extracts which have been found to have effects in traditional medicine. Cannabis, traditionally used in Asia for the treatment of pain, nausea, spasms, sleep, depression, and low appetite, is still a good candidate for the development of new compounds. If initially all attention was directed to the endocannabinoid system, recent studies suggest that many of the clinically proven effects are based on an intrinsic chain of mechanisms that do not necessarily involve only cannabinoid receptors.

The post Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain appeared first on Society of Cannabis Clinicians.

]]> Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain https://www.cannabisclinicians.org/2021/10/20/practical-strategies-using-medical-cannabis-to-reduce-harms-associated-with-long-term-opioid-use-in-chronic-pain/ Wed, 20 Oct 2021 18:03:36 +0000 https://www.cannabisclinicians.org/?p=24768 Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult population. Current United States and Canadian Chronic non-cancer pain guidelines recommend careful reassessment of the risk-benefit ratio for doses greater than 90 mg morphine equivalent dose (MED), due to low evidence for improved pain efficacy at higher morphine equivalent dose and a significant increase in morbidity and mortality. There are a number of human studies demonstrating cannabis opioid synergy. This preliminary evidence suggests a potential role of cannabis as an adjunctive therapy with or without opioids to optimize pain control.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.
To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

Many cannabinoids display promising non-hallucinogenic bioactivities that are determined by the variable nature of the side chain and prenyl group defined by the enzymes involved in their synthesis.

The post Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain https://www.cannabisclinicians.org/2021/10/20/cannabidiol-use-substitution-for-medications-and-perceptions-of-effectiveness-in-women-with-chronic-pelvic-pain/ Wed, 20 Oct 2021 17:50:04 +0000 https://www.cannabisclinicians.org/?p=24762 To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.
To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

Many cannabinoids display promising non-hallucinogenic bioactivities that are determined by the variable nature of the side chain and prenyl group defined by the enzymes involved in their synthesis.

The post Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain appeared first on Society of Cannabis Clinicians.

]]> Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees https://www.cannabisclinicians.org/2020/12/18/association-of-medical-and-adult-use-marijuana-laws-with-opioid-prescribing-for-medicaid-enrollees/ Fri, 18 Dec 2020 19:32:44 +0000 https://www.cannabisclinicians.org/?p=21079 Authors Hefei Wen, PhD; Jason M. Hockenberry, PhD Published in JAMA Internal Medicine May 2018 Abstract Importance Overprescribing of opioids is considered a major driving force behind the opioid epidemic in...

The post Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees appeared first on Society of Cannabis Clinicians.

]]> Medical Cannabis Treatment for Chronic Pain: Outcomes and Prediction of Response https://www.cannabisclinicians.org/2020/10/20/medical-cannabis-treatment-for-chronic-pain-outcomes-and-prediction-of-response/ Tue, 20 Oct 2020 21:11:41 +0000 https://www.cannabisclinicians.org/?p=20270 Authors: Joshua Aviram, Dorit Pud, Tamar Gershoni, Bareket Schiff‐Keren, Miriam Ogintz, Simon Vulfsons, Tamar Yashar, Adahan Haim‐Moshe, Silviu Brill, Howard Amital, Itay Goor‐Aryeh, Dror Robinson, Leslie Green, Refael Segal, Yacov...

The post Medical Cannabis Treatment for Chronic Pain: Outcomes and Prediction of Response appeared first on Society of Cannabis Clinicians.

]]> Delegitimizing Cannabis Because of Its Recreational Use is the Real Lie https://www.cannabisclinicians.org/2020/10/09/delegitimizing-cannabis-because-of-its-recreational-use-is-the-real-lie/ Fri, 09 Oct 2020 08:18:41 +0000 https://www.cannabisclinicians.org/?p=19895 Sherry Yafai, MD encourages the need for healthcare professionals to shift their perspective on cannabis in her column for Emergency Medicine News. "Delegitimizing medications based simply on their potential for recreational use or abuse is a dangerous and uninformed approach for physicians."

The post Delegitimizing Cannabis Because of Its Recreational Use is the Real Lie appeared first on Society of Cannabis Clinicians.

]]> Medical marijuana certification for patients with sickle cell disease: a report of a single center experience https://www.cannabisclinicians.org/2020/09/14/medical-marijuana-certification-for-patients-with-sickle-cell-disease-a-report-of-a-single-center-experience/ Mon, 14 Sep 2020 15:26:38 +0000 https://www.cannabisclinicians.org/?p=19590 Authors: Susanna A. Curtis, Dana Lew, Jonathan Spodick, Jeanne E. Hendrickson, Caterina P. Minniti, John D. Roberts Published in Blood Advances August 2020 Abstract More than one-third of adults with...

The post Medical marijuana certification for patients with sickle cell disease: a report of a single center experience appeared first on Society of Cannabis Clinicians.

]]> Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018 https://www.cannabisclinicians.org/2020/09/10/frequent-cannabis-use-and-cessation-of-injection-of-opioids-vancouver-canada-2005-2018/ Thu, 10 Sep 2020 19:08:37 +0000 https://www.cannabisclinicians.org/?p=19555 Authors: Hudson Reddon, Kora DeBeck, M Eugenia Socias, Stephanie Lake, Huiru Dong, Mohammad Karamouzian, Kanna Hayashi, Thomas Kerr, M-J Milloy Published in American Journal of Public Health August 2020 Abstract...

The post Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018 appeared first on Society of Cannabis Clinicians.

]]> Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment https://www.cannabisclinicians.org/2020/09/10/irritable-bowel-syndrome-manipulating-the-endocannabinoid-system-as-first-line-treatment/ Thu, 10 Sep 2020 18:32:32 +0000 https://www.cannabisclinicians.org/?p=19539 Authors: Viola Brugnatelli, Fabio Turco, Ulderico Freo and Gastone Zanette Published in Frontiers in Neuroscience April 2020 Introduction Irritable Bowel Syndrome (IBS) is a functional disorder characterized by abdominal pain,...

The post Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment appeared first on Society of Cannabis Clinicians.

]]> Fibromyalgia and the endocannabinoid system https://www.cannabisclinicians.org/2020/09/07/fibromyalgia-and-the-endocannabinoid-system/ Tue, 08 Sep 2020 02:03:36 +0000 https://www.cannabisclinicians.org/?p=19488 Authors: John M. McPartland Published in Science Direct November 2009 Introduction Fibromyalgia has been characterized as an ‘endocanna- binoid (eCB) deficiency syndrome’, along with other refractory maladies such as irritable...

The post Fibromyalgia and the endocannabinoid system appeared first on Society of Cannabis Clinicians.

]]>